Polymer Factory Names Acting CEO Mats Wallnér as Mignérus Departs

Polymer Factory, a nanotechnology firm specializing in dendritic materials, has announced a leadership transition. Effective September 30, 2025, Elin Mignérus will step down as CEO, following an agreement with the board of directors, as reported by Medtech Magazine. The company has not publicly disclosed the reason for her departure. Mats Wallnér, who has served as acting CEO since January, will succeed Mignérus and continue in the role. Polymer Factory develops and markets advanced dendritic materials for the medtech, pharmaceutical, and biotechnology industries. Its technology facilitates encapsulation, transport, and controlled release of substances, including pharmaceuticals, peptides, and antibiotics. These materials are crucial for research and development in life sciences and play a vital role in advanced drug delivery and other biomedical applications.